MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 250 filers reported holding MEDIVATION INC in Q2 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $727,697,000 | +35.3% | 12,067,939 | +3.2% | 0.04% | +28.6% |
Q1 2016 | $537,830,000 | -2.1% | 11,697,051 | +2.9% | 0.04% | -5.4% |
Q4 2015 | $549,579,000 | +18.5% | 11,369,030 | +4.2% | 0.04% | +117.6% |
Q3 2015 | $463,681,000 | -23.5% | 10,910,141 | +105.7% | 0.02% | -58.5% |
Q2 2015 | $605,725,000 | -5.5% | 5,304,064 | +6.8% | 0.04% | -4.7% |
Q1 2015 | $640,817,000 | +37.8% | 4,964,880 | +6.3% | 0.04% | +26.5% |
Q4 2014 | $465,176,000 | +5.9% | 4,669,973 | +5.1% | 0.03% | 0.0% |
Q3 2014 | $439,267,000 | +29.7% | 4,442,876 | +1.2% | 0.03% | +25.9% |
Q2 2014 | $338,560,000 | +15.5% | 4,392,324 | -3.6% | 0.03% | +8.0% |
Q1 2014 | $293,145,000 | +9.2% | 4,554,070 | +8.3% | 0.02% | +4.2% |
Q4 2013 | $268,437,000 | +10.8% | 4,206,158 | +4.1% | 0.02% | 0.0% |
Q3 2013 | $242,208,000 | +25.5% | 4,040,839 | +3.0% | 0.02% | +20.0% |
Q2 2013 | $193,016,000 | – | 3,923,080 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |